Clinical Trials Browser

OTHER × Sarcoma × cemiplimab × Clear all

NCT06528769 2025-09-30

Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

Phase 2 Recruiting

Leiomyosarcoma, Sarcoma

NCT04873375 2024-10-31

Cemiplimab for Secondary Angiosarcomas

Phase 2 Completed

Hemangiosarcoma, Neoplasm Metastasis, Sarcoma